Clinical outcomes in patients with FLT3-ITD-mutated relapsed/refractory acute myelogenous leukemia undergoing hematopoietic stem cell transplantation after quizartinib or salvage chemotherapy in the QuANTUM-R trial - Ganguly, Siddhartha; Cortes, Jorge E.; Krämer, Alwin; Levis, Mark J.; Martinelli, Giovanni; Perl, Alexander E.; Russell, Nigel H.; Arunachalam, Meena; Santos, Cedric Dos; Gammon, Guy; Lesegretain, Arnaud; Mires, Derek E.; et al. (Transplantation and cellular therapy, 2021)
Available online 21 December 2020